# Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer

> **NCT02681601** · NA · TERMINATED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Cancer of Pancreas

## Interventions

- **DIETARY_SUPPLEMENT:** Nutrawell Powder
- **OTHER:** Diet Only
- **DIETARY_SUPPLEMENT:** OmegaRich fish oil supplement

## Key facts

- **NCT ID:** NCT02681601
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07-19
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2022-08-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02681601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02681601, "Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02681601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*